Special NoticeActive77344426S0002
Health Sector Supply Chain Fragility and Investment Prioritization Support Services
UNITED STATES INTERNATIONAL DEVELOPMENT FINANCE CORPORATION / UNITED STATES INTERNATIONAL DEVELOPMENT FINANCE CORPORATION / OFFICE OF ACQUISITIONKey dates?
- Posted?
- Aug 27, 2026
- Response deadline?
- Aug 31, 2026, 8:30 PM UTC
- Archive date?
- Sep 15, 2026
- Archive type?
- auto15
Classification?
- Notice type?
- Special Notice
- Base type?
- Special Notice
- Set-aside?
- No Set aside used
- Set-aside code?
- NONE
- PSC?
- —
NAICS?
Issuing office?
- Department?
- UNITED STATES INTERNATIONAL DEVELOPMENT FINANCE CORPORATION
- Sub-tier?
- UNITED STATES INTERNATIONAL DEVELOPMENT FINANCE CORPORATION
- Office?
- OFFICE OF ACQUISITION
- Office code?
- 077.7700.773444
- Organization type?
- OFFICE
- Office address?
- Washington, DC, 20527, USA
Place of performance?
- Street?
- —
- Street 2?
- —
- City?
- —
- State?
- District of Columbia
- Zip?
- —
- Country?
- UNITED STATES
Contacts?
- Melissa Hergenraderprimary
- Aaron McKellumsecondary
Description?
Notice of Sole Source Intent The U.S. International Development Finance Corporation (DFC) intends to award a one-year, sole source purchase order to API Innovation Center (APIIC) for specialized analytical, technical, data integration, prioritization, reporting, and briefing support to identify, assess, prioritize, and act on pharmaceutical and health-sector supply chain vulnerabilities that may present development finance, investment, counter-dependency, resilience, and strategic supply chain opportunities. The requirement is for a highly specialized contractor capable of producing a national fragility analysis; integrating multiple pharmaceuticals, manufacturing, regulatory, utilization, geopolitical, and risk datasets; assessing API-level supply chain dependency; supporting DFC-calibrated model weighting; prioritizing candidate drugs; and preparing approximately 20–30 drug-specific supply chain reports. The work requires detailed visibility into active pharmaceutical ingredient (API) production, finished dosage form (FDF) manufacturing, key starting material (KSM) and upstream dependencies, manufacturer and facility-level concentration, country-specific dependency risks, and financeable opportunities to reduce supply chain fragility. This contract action is for services for which the government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b). Interested vendors may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received by Monday, August 31, 2026, at 4:30pm Eastern Time (ET) will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the Contracting Officer, Melissa Hergenrader, at melissa.hergenrader@dfc.gov by Monday, August 31, 2026, at 4:30pm ET.
Similar open contracts
Metadata?
- Notice ID?
- 8bb80217267a4e4eb12ca5bc59faf17a
- Full path?
- UNITED STATES INTERNATIONAL DEVELOPMENT FINANCE CORPORATION.UNITED STATES INTERNATIONAL DEVELOPMENT FINANCE CORPORATION.OFFICE OF ACQUISITION
- Office code?
- 077.7700.773444
- Ingested?
- Aug 28, 2026
- Updated?
- Sep 13, 2026